Maia Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.35M Sell
6,126
-27
-0.4% -$27.6K 1.08% 18
2026
Q1
$5.66M Buy
6,153
+509
+9% +$516K 0.96% 21
2025
Q4
$5.86M Buy
5,644
+224
+4% +$214K 1% 20
2025
Q3
$5.24M Buy
5,420
+1,426
+36% +$1.06M 0.88% 22
2025
Q2
$3.11M Buy
3,994
+901
+29% +$700K 0.59% 43
2025
Q1
$2.33M Buy
3,093
+565
+22% +$470K 0.53% 48
2024
Q4
$2.04M Buy
2,528
+113
+5% +$93.6K 0.44% 53
2024
Q3
$2.15M Buy
2,415
+229
+10% +$206K 0.53% 45
2024
Q2
$2.08M Buy
+2,186
New +$1.75M 0.63% 42
2023
Q4
$1.28M Buy
+2,196
New +$1.28M 0.52% 46

Other funds holding LLY

Maia Wealth's LLY Position: Q2 2026 in Review

Maia Wealth reduced its Eli Lilly (LLY) stake by 0.44% in Q2 2026, selling an estimated $27.6K and leaving 6,126 shares worth $7.35M. The position accounts for 1.08% of the portfolio, ranked #18.

Maia Wealth first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. 4,628 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Maia Wealth held 6,126 shares of Eli Lilly worth $7.35M as of Q2 2026.
  • Maia Wealth sold 27 Eli Lilly shares in Q2 2026, an estimated $27.6K.
  • Eli Lilly made up 1.08% of Maia Wealth's portfolio in Q2 2026, its #18 holding.
  • Maia Wealth first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • 4,628 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Maia Wealth's 13F filing for Q2 2026, filed 28 Jul 2026.